BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9727721)

  • 1. Transforming growth factor-beta1 in plasma and liver of children with liver disease.
    Rosensweig JN; Omori M; Page K; Potter CJ; Perlman EJ; Thorgeirsson SS; Schwarz KB
    Pediatr Res; 1998 Sep; 44(3):402-9. PubMed ID: 9727721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
    Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
    Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
    Tsau YK; Jou ST; Ni YH
    Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional basis for hepatic fibrosis in cystic fibrosis-associated liver disease.
    Pereira TN; Lewindon PJ; Greer RM; Hoskins AC; Williamson RM; Shepherd RW; Ramm GA
    J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):328-35. PubMed ID: 22157922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal activation of OPN inflammation pathway in livers of children with biliary atresia and relationship to hepatic fibrosis.
    Huang L; Wei MF; Feng JX
    Eur J Pediatr Surg; 2008 Aug; 18(4):224-9. PubMed ID: 18704890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.
    Lewindon PJ; Pereira TN; Hoskins AC; Bridle KR; Williamson RM; Shepherd RW; Ramm GA
    Am J Pathol; 2002 May; 160(5):1705-15. PubMed ID: 12000722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.
    Smith JL; Lewindon PJ; Hoskins AC; Pereira TN; Setchell KD; O'Connell NC; Shepherd RW; Ramm GA
    Hepatology; 2004 Jun; 39(6):1673-82. PubMed ID: 15185309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney volume and plasma hepatocyte growth factor-transforming growth factor beta1 ratio among children with biliary atresia before and after liver transplantation: the reversibility of nephromegaly.
    Cheng CH; Tsau YK; Tsai IJ
    Am J Kidney Dis; 2005 Nov; 46(5):830-6. PubMed ID: 16253722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of transforming growth factor (TGF)-beta 1 does not predict advanced liver fibrosis in children with chronic hepatitis B.
    Lebensztejn DM; Sobaniec-Lotowska M; Kaczmarski M; Werpachowska I; Sienkiewicz J
    Hepatogastroenterology; 2004; 51(55):229-33. PubMed ID: 15011870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of transforming growth factor beta1 (TGF-beta1) in the pathogenesis and clinical course of chronic hepatitis in children].
    Liberek A; Marek A; Kmieć Z; Kartanowicz D; Szlagatys-Sidorkiewicz A; Łuczak G; Wierzbicki PM; Stanisławowski M; Wierzbicki M; Marek K; Liberek T; Sikorska-Wiśniewska G; Góra-Gebka M; Wegrzyn G; Kamińska B
    Med Wieku Rozwoj; 2009; 13(3):163-70. PubMed ID: 20081261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ki-67, transforming growth factor beta1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases.
    Piekarska A; Piekarski J; Omulecka A; Szymczak W; Kubiak R
    J Gastroenterol Hepatol; 2006 Apr; 21(4):700-10. PubMed ID: 16677156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease.
    Pereira TN; Lewindon PJ; Smith JL; Murphy TL; Lincoln DJ; Shepherd RW; Ramm GA
    J Hepatol; 2004 Oct; 41(4):576-83. PubMed ID: 15464237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of plasma transforming growth factor beta1 levels in stable nonatopic asthma.
    Joseph J; Benedict S; Badrinath P; Wassef S; Joseph M; Abdulkhalik S; Nicholls MG
    Ann Allergy Asthma Immunol; 2003 Nov; 91(5):472-6. PubMed ID: 14692431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
    Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.